CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
Novus Biologicals | Catalog # NBP2-24867
Clone OKT3 was used by HLDA to establish CD designation.
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Cited:
Human, Mouse
Applications
Validated:
Immunoblotting, Flow Cytometry, Flow (Cell Surface), Functional, In vitro assay, In vivo assay, CyTOF-ready
Cited:
Flow Cytometry, In vitro assay, In vivo assay, Functional Assay
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # OKT3
Format
Low Endotoxin, Azide and BSA Free
Loading...
Product Specifications
Immunogen
This CD3 antibody was developed against human PBMCs.
Reactivity Notes
Mouse reactivity reported in scientific literature (PMID: 25485679)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Theoretical MW
23.1 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Description
Novus Biologicals Mouse CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free (NBP2-25186) is a monoclonal antibody validated for use in Flow. Anti-CD3 Antibody: Cited in 8 publications. All Novus Biologicals antibodies are covered by our 100% guarantee.
Endotoxin Level
Endotoxin amounts will vary lot to lot, but should be less than 0.03 EU/ug.
Scientific Data Images for CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free [NBP2-24867]
Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin and Azide Free [NBP2-24867] - Analysis using Alexa Fluor (R) 488 conjugate of NBP2-24867. A cell surface stain was performed on hPBMCs with CD8 Alpha antibody (RPA-T8) NBP2-25195 (top image) and a matched isotype control NBP2-27287 (bottom image). Cells were incubated in an antibody dilution of 1:200 for 20 minutes at room temperature. Both antibodies were conjugated to PerCP. A co-stain was also performed using CD3 antibody NBP2-24867AF488.Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free [NBP2-24867]
Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin and Azide Free [NBP2-24867] - Analysis of CD3+ hPMBCs using the APC conjugate of this antibody. A cell surface stain was performed on CD3+ hPBMCs with V alpha 24 J alpha 18 TCR antibody (6B11) NBP2-00267PE (top image) and a matched isotype control NBP2-27287 (bottom image). Cells were incubated in an antibody dilution of 1 ug/mL for 20 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin. A co-stain was also performed using CD3 antibody NBP2-24867APC.Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free [NBP2-24867]
Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin and Azide Free [NBP2-24867] - Analysis of PerCP conjugate of NBP2-25186. A surface stain was performed on Jurkat cells with CD3 (OKT3) antibody NBP2-24867PCP (blue) and a matched isotype control (orange). Cells were incubated in an antibody dilution of 2.5 ug/mL for 20 minutes at room temperature.Flow (Cell Surface): CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free [NBP2-24867]
Flow (Cell Surface): CD3 Antibody (OKT3) - Low Endotoxin and Azide Free [NBP2-24867] - Analysis using the Alexa Fluor (R) 488 conjugate of NBP2-24867. Detection of CD3 expression in hPBMc's gated to lymphocyte population at 1 x 10^6 cells/mL. Cells were stained with NBP2-24867AF488 (orange) conjugate at a 1:500 dilution. Results are shown with mIgG2 (AF488 conjugate) isotype control (blue).Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free [NBP2-24867]
Flow Cytometry: CD3 Antibody (OKT3) - Low Endotoxin and Azide Free [NBP2-24867] - Analysis using the Alexa Fluor (R) 700 conjugate of NBP2-24867. Staining of human PBMC. Flow cytomerty image submitted by a verified customer review.Flow (Cell Surface): CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free [NBP2-24867]
Flow (Cell Surface): CD3 Antibody (OKT3) - Low Endotoxin and Azide Free [NBP2-24867] - Analysis using the PE conjugate of NBP2-24867. Detection of CD3 expression in hPBMC's gated to lymphocyte population at 1 x 10^6 cells/ml. Cells were stained with NBP2-24867PE (orange) conjugate at a 1:500 dilution.Applications for CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
Application
Recommended Usage
Flow Cytometry
1 uL / 1 million cells
Immunoblotting
reported in scientific literature (PMID 23880762)
In vitro assay
reported in scientific literature (PMID 26084721)
In vivo assay
reported in scientific literature (PMID 25535359)
Flow Cytometry Panel Builder
Bio-Techne Knows Flow Cytometry
Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.
Advanced Features
- Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
- Spillover Popups - Visualize the spectra of individual fluorochromes
- Antigen Density Selector - Match fluorochrome brightness with antigen density
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
Sterile - filtered PBS
Format
Low Endotoxin, Azide and BSA Free
Preservative
No Preservative
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CD3
CD3 proteins are expressed on the surface of thymocytes during thymocyte development, proliferation, and maturation to T-cells (4, 6, 7). During T-cell development CD4-CD8- double negative (DN) cells differentiate to CD4+CD8+ double positive (DP) cells before progressing to single positive (SP) CD4+ helper T-cells or CD8+ cytotoxic T-cells (4, 6, 7). As CD3 plays an important role in thymocyte development, it is understandable that CD3 defects and mutations in CD3 protein chains cause severe combined immunodeficiencies (SCIDs) (8). Additionally, a subset of CD3+ T-cells that co-express CD20 are described in a variety of diseases including rheumatoid arthritis, multiple sclerosis, CD20+ T-cell leukemia/lymphoma, and HIV (9). Clinical trials and animal models have shown that anti-CD3 monoclonal antibodies are a promising treatment modality for inflammatory disorders and autoimmune diseases, such as type I diabetes (10).
References
1. Chetty, R., & Gatter, K. (1994). CD3: structure, function, and role of immunostaining in clinical practice. The Journal of pathology. https://doi.org/10.1002/path.1711730404
2. Mariuzza, R. A., Agnihotri, P., & Orban, J. (2020). The structural basis of T-cell receptor (TCR) activation: An enduring enigma. The Journal of biological chemistry. https://doi.org/10.1074/jbc.REV119.009411
3. Kuhns, M. S., Davis, M. M., & Garcia, K. C. (2006). Deconstructing the form and function of the TCR/CD3 complex. Immunity. https://doi.org/10.1016/j.immuni.2006.01.006
4. Clevers, H., Alarcon, B., Wileman, T., & Terhorst, C. (1988). The T cell receptor/CD3 complex: a dynamic protein ensemble. Annual review of immunology. https://doi.org/10.1146/annurev.iy.06.040188.003213
5. Uniprot: CD3-delta (P04234), CD3-epsilon (P07766), CD3-gamma (P09693), CD3-zeta (P20963)
6. D'Acquisto, F., & Crompton, T. (2011). CD3+CD4-CD8- (double negative) T cells: saviours or villains of the immune response?. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2011.05.019
7. Dave V. P. (2009). Hierarchical role of CD3 chains in thymocyte development. Immunological reviews. https://doi.org/10.1111/j.1600-065X.2009.00835.x
8. Fischer, A., de Saint Basile, G., & Le Deist, F. (2005). CD3 deficiencies. Current opinion in allergy and clinical immunology. https://doi.org/10.1097/01.all.0000191886.12645.79
9. Chen, Q., Yuan, S., Sun, H., & Peng, L. (2019). CD3+CD20+ T cells and their roles in human diseases. Human immunology. https://doi.org/10.1016/j.humimm.2019.01.001
10. Kuhn, C., & Weiner, H. L. (2016). Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside. Immunotherapy. https://doi.org/10.2217/imt-2016-0049
Alternate Names
CD_antigen: CD3e, CD3 antigen, delta subunit, CD3d antigen, CD3d antigen, delta polypeptide (TiT3 complex), CD3d molecule, delta (CD3-TCR complex), CD3-DELTA, CD3e, CD3e antigen, CD3e antigen, epsilon polypeptide (TiT3 complex), CD3e molecule, epsilon (CD3-TCR complex), CD3-epsilon, CD3G, CD3g antigen, CD3g antigen, gamma polypeptide (TiT3 complex), CD3g molecule, epsilon (CD3-TCR complex), CD3g molecule, gamma (CD3-TCR complex), CD3-GAMMA, FLJ17620, FLJ17664, FLJ18683, FLJ79544, FLJ94613, IMD18, MGC138597, T3DOKT3, delta chain, T3E, T-cell antigen receptor complex, epsilon subunit of T3, T-cell receptor T3 delta chain, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, TCRE, anti-CD3 okt3, Muromonab, okt3, okt3 ab, okt3 CD3, okt3 hybridoma
Gene Symbol
CD3E
Additional CD3 Products
Product Documents for CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
Product Specific Notices for CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Related Research Areas
Citations for CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
Customer Reviews for CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
There are currently no reviews for this product. Be the first to review CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free and earn rewards!
Have you used CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- 7-Amino Actinomycin D (7-AAD) Cell Viability Flow Cytometry Protocol
- Cellular Response to Hypoxia Protocols
- Extracellular Membrane Flow Cytometry Protocol
- Flow Cytometry Protocol for Cell Surface Markers
- Flow Cytometry Protocol for Staining Membrane Associated Proteins
- Flow Cytometry Staining Protocols
- Flow Cytometry Troubleshooting Guide
- Intracellular Flow Cytometry Protocol Using Alcohol (Methanol)
- Intracellular Flow Cytometry Protocol Using Detergents
- Intracellular Nuclear Staining Flow Cytometry Protocol Using Detergents
- Intracellular Staining Flow Cytometry Protocol Using Alcohol Permeabilization
- Intracellular Staining Flow Cytometry Protocol Using Detergents to Permeabilize Cells
- Propidium Iodide Cell Viability Flow Cytometry Protocol
- Protocol for the Characterization of Human Th22 Cells
- Protocol for the Characterization of Human Th9 Cells
- Protocol: Annexin V and PI Staining by Flow Cytometry
- Protocol: Annexin V and PI Staining for Apoptosis by Flow Cytometry
- R&D Systems Quality Control Western Blot Protocol
- Troubleshooting Guide: Fluorokine Flow Cytometry Kits
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars
FAQs for CD3 Antibody (OKT3) - Low Endotoxin, Azide and BSA Free
Showing
1
-
1 of
1 FAQ
Showing All
-
A: All of Novus' antibodies, including NBP2-24867, are for laboratory research use only, not for any clinical diagnostics or therapeutic treatment. Therefore, this antibody has not been tested for the presence of any virus, as required by the rules of GMP for all clinical products.